Intracranial Aneurysm Market Growth & Trends
The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.
Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.
A recent Global Burden of Disease study predicts a doubling of individuals affected by brain diseases by 2050, with about 40% of the current global population already impacted. Technological advancements and increasing preference for targeted therapy approach are factors expected to drive the market growth in the forecast period.
The prevalence of a variety of health disorders, including brain aneurysms, increases as the world’s population ages. Elderly individuals are more likely to develop aneurysms, especially in the brain. For instance, as per the reports published by University Of Minnesota in March 2023, the Brain Aneurysm Foundation states that 1 in 50 Americans or approximately 6.7 million people-have an unruptured brain aneurysm. Annually, about 30,000 individuals in the nation experience the rupture of a brain aneurysm, translating to roughly one rupture occurring every 18 minutes.
Request a free sample copy or view report summary: Intracranial Aneurysm Market Report
Intracranial Aneurysm Market Report Highlights
- In 2023, the endovascular coiling segment dominated the market with a share of 84.6%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas
- The hospitals end-use segment held the largest revenue share of 89.52% in 2023. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals
- North America dominated the market with a share of 26.65% in 2023. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships
- Thus, the presence of key players in North America is expected to boost the regional market growth
Regional Insights
North America dominated the market with the revenue share of 26.65% in 2023 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke. In addition, the increasing occurrence of intracranial aneurysms and the escalating demand for minimally invasive surgeries are driving the market growth in this region. Moreover, numerous initiatives being taken by different organizations are expected to boost market growth. For example, The Bee Foundation (TBF), a non-profit entity, is dedicated to raising awareness and decreasing the mortality rates associated with cerebral aneurysms via pioneering research.
Intracranial Aneurysm Market Segmentation
Grand View Research has segmented the global intracranial aneurysm market based on type, end-use, and region:
Intracranial Aneurysm Type Outlook (Revenue, USD Million, 2018 – 2030)
- Surgical Clipping
- Endovascular Coiling
- Flow Diverters
- Others
Intracranial Aneurysm End-use Outlook (Revenue, USD Million, 2018 – 2030)
- Hospitals
- Clinics
- Others
Intracranial Aneurysm Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players of Intracranial Aneurysm Market
- Medtronic plc
- Stryker Corporation
- MicroPort Scientific Corporation.
- Johnson & Johnson Services, Inc.
- MicroVention Inc.
- B. Braun Melsungen AG
- Integra LifeSciences
- RAUMEDIC AG
- Terumo Corporation
- Delta Surgical
Browse Full Report: Intracranial Aneurysm Market Report